Transpersonal Psychologist Dr. Sheila Krystal to be Featured on Close Up Radio

BERKLEY, CALIFORNIA, UNITED STATES, October 27, 2020 /EINPresswire.com/ — Right now, the collective human race is concerned with the COVID-19 pandemic. Loved ones are getting sick. People are suffering from financial distress. Some are paralyzed by fear. Others are angry or depressed.

But there are silver linings in this dark cloud. We must refocus our attention in ways that are productive instead of destructive. What we pay attention to most determines our emotions and mood. We can stay optimistic, more positive, more centered, when we work with our brain’s neuroplasticity.

“When we all go to sleep at night, we are awash in the collective unconscious, which since COVID-19, contains fear, anger, impatience and depression,” says transpersonal psychologist Dr. Sheila Krystal. “Many of us wake up afraid. Some are even having panic attacks, and the sympathetic nervous system is on full blast. My hope is to help people know what to do when that happens.”

According to Dr. Krystal, psychological work must include all 4 dimensions: the physical body (improving health, diet, exercise, sleep), the emotional plane and autonomic nervous system regulation, the mental realm and quieting the monkey mind and finally the spiritual dimension promoting more reliance on the inner world and on mindfulness.

“People don’t have to be victims of their conditioning and past and trauma,” says Dr. Krystal. “We now understand that the brain can change itself, and we can participate in that change by focusing our attention on the present moment and what is positive in our lives and count our blessings. If we focus only on gratitude and appreciation for a minimum of thirty seconds, we can participate in our brain’s neuroplasticity and create and reinforce new neural networks for optimism, positivity and compassion.”

Indeed, the virus has given us the opportunity to reexamine our priorities. Dr. Krystal recommends finding a therapist who offers eye movement desensitization and reprocessing (EMDR) and mindfulness training, especially for trauma.

“I work with meditation, centering self-awareness techniques, visualization, CBT and EMDR with clients,” says Dr. Krystal.

Close Up Radio will feature Dr. Sheila Krystal in an interview with Jim Masters on October 29th at 2pm EST

Listen to the show on BlogTalkRadio

If you have any questions for our guest, please call (347) 996-3389

Lou Ceparano
Close Up Television & Radio
+ +1 (631) 850-3314
email us here
Visit us on social media:
Facebook


Source: EIN Presswire

Historic Billion-Dollar Settlement Renews Hope for Those Struggling With Opioid Use

Waismann Method® Advanced Treatment of Opiate Dependence

Waismann Method® Advanced Treatment of Opiate Dependence

Clare Waismann, Certified Addiction Treatment Counselor, founder of Waismann Method® and Domus Retreat®

Clare Waismann, Certified Addiction Treatment Counselor, founder of Waismann Method® and Domus Retreat®

Michael Lowenstein, M.D., Waismann Method® Medical Director

Michael Lowenstein, M.D., Waismann Method® Medical Director

A historic settlement against OxyContin maker, Purdue Pharma, can provide financial relief plus well-deserved justice for the victims of the opioid crisis.

May [the money] provide those who desire to come off opioids the ability to receive adequate medical care through the withdrawal phase, followed by the necessary professional mental health support.”

— Clare Waismann

BEVERLY HILLS, CALIFORNIA, UNITED STATES, October 27, 2020 /EINPresswire.com/ — On Wednesday, the Justice Department announced that OxyContin-maker Purdue Pharma agreed to plead guilty to three felony criminal charges including violating the anti-kickback laws and conspiracy to defraud the United States. The historic $8.3 billion settlement — the largest such settlement ever reached with a pharmaceutical company — is the result of a years-long criminal investigation. The penalties include a criminal fine of $3.544 billion. Purdue must make a direct payment of $225 million to the government as part of a larger $2 billion criminal forfeiture.

The Sackler family will lose control over their company. Subject to approval by the bankruptcy court of the Southern District of New York, the company would cease to operate in its current form and would be governed by a trust as a public benefit company (PBC). The trust is designed to benefit the American public. The Department of Justice is willing to credit up to $1.775 billion against the $2 billion and channel that to State and local governments.

Jeff Rosen, Deputy Attorney General, said that this settlement “will redress past wrongs, and will also provide extraordinary new resources for treatment and care of those affected by opioid addiction.”

Compensating victims and funding effective treatment centers is the right thing to do, and it makes sense economically. The CDC estimates that the total “economic burden” of opioid misuse in this country is about $78.5 billion each year.

Clare Waismann, the founder of Waismann Method® Advanced Treatment of Opiate Dependence and Domus Retreat, is hopeful these funds will make a difference in victims’ lives.

“May the money be used wisely to educate, prevent, and treat our citizens. May it also provide those who desire to come off opioids the ability to receive adequate medical care in a hospital through the withdrawal phase, followed by the necessary professional mental health support,” Clare said.

This settlement can provide a financial reward, and some well-deserved justice for those individuals who became victims of the opioid crisis.

Individuals continue to seek numbing devices to self-medicate the emotional distress that continuously overwhelms them. Convincing people that they are “addicts” or have an “addictive personality” is unproductive and harmful.

We need to see them, hear them, and, most of all, understand their struggles. Let us replace condemnation with education, mental health care, and medical treatment when needed. Only then, will we really start saving lives.

For more information about Waismann Method®, please visit www.opiates.com. For interviews, contact Clare Waismann at 800-423-2482 or send an email to info@opiates.com.

About Waismann Method® Opioid Treatment Specialists

Clare Waismann is the founder of Waismann Method® and is a Certified Addiction Treatment Counselor. For over 21 years, Waismann Method® has successfully treated thousands of patients struggling with opioid use disorder. Clare has spent over two decades tirelessly fighting to increase access to medically-assisted detox, mental health care and to end the unjust stigma associated with opioid use disorder.

Waismann Method® provides opioid users with the highest level of individualized medical-based detoxification treatment. The center’s medical director, Dr. Michael H. Lowenstein, is a quadruple board-certified M.D. He is highly recognized for his expertise in medically-assisted opioid treatment (including rapid detox), the successful management of pain, and anesthesiology. Trusted since 1998, patients from around the world have come to the facility located exclusively in Southern California for treatment of opioid dependence in a private, full-service accredited hospital.

Clare Waismann
Waismann Method
+1 800-423-2482
info@opiates.com
Visit us on social media:
Facebook
Twitter
LinkedIn


Source: EIN Presswire

Inhalation Sedatives Market Trend: Production Of Generic Inhalation Sedatives

Inhalation Sedatives Market Report 2020-30: COVID-19 Growth And Change

Inhalation Sedatives Global Market Report 2020-30: COVID-19 Growth And Change

The Business Research Company’s Global Inhalation Sedatives Market Report 2020-30: COVID-19 Growth And Change

LONDON, GREATER LONDON, UK, October 27, 2020 /EINPresswire.com/ — The production of generic inhalation sedatives is expected to be an emerging trend in the inhalation sedatives market. Generics are a type of drug that have the same chemical formula, dosage form, dose and effect as that of the patented drug, but are produced by companies when the patent expires. Generic inhalation sedatives production has increased over the last few years. For instance, in January 2019, Novartis’ division Sandoz launched a liquid for inhalation called desflurane in the United States, a first generic of an inhalation agent suprane that is used for induction and maintenance in adults and paediatrics. Health Canada has given a receipt of a drug identification number to Blue-Zone Technologies Ltd that permits it to launch the generic desflurane drug. Therefore, the production of generic inhalation sedatives is expected to become the new trend in the inhalation sedatives market.

The global inhalation sedatives market size is expected to increase from $1.27 billion in 2019 to $1.29 billion in 2020 at a compound annual growth rate (CAGR) of 1.2%. The growth is mainly due to the COVID-19 outbreak. The infected individuals with severe ARDS require sedation most frequently, and inhalation sedatives are being increasingly considered as they are associated with rapid onset of inhalation and effective outcomes. Inhaled sedatives can reduce lung inflammation, shorten the duration of ventilation and potentially improve survival. The global inhalation sedatives market share is then expected to stabilize and reach $1.48 billion in 2023 at a CAGR of 4.8%.

The short onset and duration time of inhalation sedatives is expected to drive the inhalation sedative market. Rapid onset of inhalation sedative and quick recovery rate makes it applicable for short procedures especially in dental surgeries of paediatrics, and in intensive care units, for decreasing the pain and quick recovery. For instance, the most commonly used inhaled sedative is nitrous oxide dosage, which is administered as a mixture of 30-70% of oxygen, takes about 1-2 minutes to act, and the duration of action is 5 minutes. The short time required for the onset of action and its short duration makes nitrous oxide the most used inhalation sedative for dental treatment. Therefore, the short onset and duration time of inhalation sedatives is expected to drive the inhalation sedatives market.

The inhalation sedatives market consists of sales of inhalation sedatives by companies who manufacture them. Inhalation sedatives are the drugs used to induce or maintain inhalation sedation, which is a type of conscious sedation where a drug is inhaled to suppress the central nervous system activity so that there is not much stress on the patient during a surgical process or a treatment, and so that patient responds to the physician’s commands without protective reflexes. Inhalation sedatives are used in hospitals, ambulatory surgical centers and other care providing centers.

Here Is A List Of Similar Reports By The Business Research Company:

Intravenous Infusion Pump Global Market Report 2020-30: COVID 19 Growth And Change
(https://www.thebusinessresearchcompany.com/report/intravenous-infusion-pump-global-market-report-2020-30-covid-19-growth-and-change)

Implantable Infusion Pumps Global Market Report 2020-30: COVID 19 Growth And Change
(https://www.thebusinessresearchcompany.com/report/implantable-infusion-pumps-global-market-report-2020-30-covid-19-growth-and-change)

Interested to know more about The Business Research Company?
The Business Research Company is a market intelligence firm that excels in company, market, and consumer research. Located globally it has specialist consultants in a wide range of industries including manufacturing, healthcare, financial services, chemicals, and technology.

Oliver Guirdham
The Business Research Company
+44 20 7193 0708
email us here
Visit us on social media:
Facebook
Twitter
LinkedIn


Source: EIN Presswire

Mask Customization Market – Global Industry Analysis, Size, Share, Growth, Trends and Forecast 2020 – 2026

Latest Market Analysis Research Report on “Global Mask Customization Market 2020” has been added to Wise Guy Reports database.

PUNE , MAHARASHTRA, INDIA, October 27, 2020 /EINPresswire.com/ — Global Mask Customization Industry

New Study Reports “Mask Customization Market 2020 Global Market Opportunities, Challenges, Strategies and Forecasts 2026” has been Added on WiseGuyReports.

Overview

This market overview report gives a compelling market insight into that Global Mask Customization Market. Those market insights include its products & services, technology utilization, innovations, resource management, etc. It also puts some focus on the demand and supply graph of this Mask Customization Market. It also gives market segment knowledge and recent market trends. The main thing is that this report gives a piece of overall information about customer satisfaction and also analyzed whether the products & services reach up to each end-user or not. This report analyzed a market potentiality from every required prospective and has taken 2020 as the forecast year.

The key players covered in this study
Customink
Etsy
Vistaprint
Zazzle
Canvasdiscount
Signs
Realthread
Spreadshirt
Bagsoflove
Printful
Printerpix

Try Sample of Global Mask Customization Market @    https://www.wiseguyreports.com/sample-request/5974364-global-mask-customization-market-size-status-and-forecast-2020-2026

Market segment by Type, the product can be split into
Cotton
PVC
Non-Woven Polypropylene
Ethylene-vinyl Acetate

Market segment by Application, split into
Medical Protection
Daily Use

Analysis of market dynamics

This report introduced the whole market dynamics in a global context. Its market analysis part has quite effective, and analysts have focused on this Global Mask Customization Market's various market dimensions. This market analysis gives much relevant information about recent market trends, market competition levels, new competitors, market movement, etc. that can help this Mask Customization Market towards growth improvement. This report also tells about competitor's pricing model, their product uniqueness, revenue generation, etc. This report also described expected risks, which can help that Global Mask Customization Market avoid them up to a certain level. Analysts have examined this Mask Customization Market's market movement and stated reasons for its upward or downward movement.

Market segment analysis

Segmental analysis is quite essential to know the market potentiality in a global scenario. Also, this report examined the Global Mask Customization Market's impact on other market segments. This segmental description can help that Mask Customization Market improve its product & service level, strategies, USP, etc. along with future opportunities. This report has prepared by taking multiple marketing aspects into account, such as sales volume, cash flow management, resources management, labor management, budget planning, etc. that can help that Global Mask Customization Market sustains in the long run.

Key players

This report gives all the required information about this Global Mask Customization Market's vendors. It will help this Global Mask Customization Market to improve its quality and performance level. It tells about all market functionality of key players, their strategies, technology adoption, etc. This report will help this Mask Customization Market to reach up to its customers. 

Report covers:

Comprehensive research methodology of Global Mask Customization Market.
This report also includes detailed and extensive market overview with gap analysis, historical analysis & key analyst insights.
An exhaustive analysis of macro and micro factors influencing the market guided by key recommendations.
Analysis of regional regulations and other government policies impacting the Global Mask Customization Market.
Insights about market determinants which are stimulating the Global Mask Customization Market.
Detailed and extensive market segments with regional distribution of forecasted revenues
Extensive profiles and recent developments of market players

If you have any enquiry before buying a copy of this report @ https://www.wiseguyreports.com/enquiry/5974364-global-mask-customization-market-size-status-and-forecast-2020-2026

Some points from table of content:

1 Report Overview
2 Global Growth Trends
3 Competition Landscape by Key Players
4 Mask Customization Breakdown Data by Type
5 Mask Customization Breakdown Data by Application
6 North America
7 Europe
8 Asia-Pacific
9 Latin America
10 Middle East & Africa
11Key Players Profiles
11.1 Customink
11.1.1 Customink Company Details
11.1.2 Customink Business Overview
11.1.3 Customink Mask Customization Introduction
11.1.4 Customink Revenue in Mask Customization Business (2015-2020))
11.1.5 Customink Recent Development
11.2 Etsy
11.2.1 Etsy Company Details
11.2.2 Etsy Business Overview
11.2.3 Etsy Mask Customization Introduction
11.2.4 Etsy Revenue in Mask Customization Business (2015-2020)
11.2.5 Etsy Recent Development
11.3 Vistaprint
11.3.1 Vistaprint Company Details
11.3.2 Vistaprint Business Overview
11.3.3 Vistaprint Mask Customization Introduction
11.3.4 Vistaprint Revenue in Mask Customization Business (2015-2020)
11.3.5 Vistaprint Recent Development
11.4 Zazzle
11.4.1 Zazzle Company Details
11.4.2 Zazzle Business Overview
11.4.3 Zazzle Mask Customization Introduction
11.4.4 Zazzle Revenue in Mask Customization Business (2015-2020)
11.4.5 Zazzle Recent Development
11.5 Canvasdiscount
11.5.1 Canvasdiscount Company Details
11.5.2 Canvasdiscount Business Overview
11.5.3 Canvasdiscount Mask Customization Introduction
11.5.4 Canvasdiscount Revenue in Mask Customization Business (2015-2020)
11.5.5 Canvasdiscount Recent Development
11.6 Signs
11.6.1 Signs Company Details
11.6.2 Signs Business Overview
11.6.3 Signs Mask Customization Introduction
11.6.4 Signs Revenue in Mask Customization Business (2015-2020)
11.6.5 Signs Recent Development
11.7 Realthread
11.7.1 Realthread Company Details
11.7.2 Realthread Business Overview
11.7.3 Realthread Mask Customization Introduction
11.7.4 Realthread Revenue in Mask Customization Business (2015-2020)
11.7.5 Realthread Recent Development
11.8 Spreadshirt
11.8.1 Spreadshirt Company Details
11.8.2 Spreadshirt Business Overview
11.8.3 Spreadshirt Mask Customization Introduction
11.8.4 Spreadshirt Revenue in Mask Customization Business (2015-2020)
11.8.5 Spreadshirt Recent Development
11.9 Bagsoflove
11.9.1 Bagsoflove Company Details
11.9.2 Bagsoflove Business Overview
11.9.3 Bagsoflove Mask Customization Introduction
11.9.4 Bagsoflove Revenue in Mask Customization Business (2015-2020)
11.9.5 Bagsoflove Recent Development
11.10 Printful
11.11 Printerpix
11.12 Yourprint
12Analyst's Viewpoints/Conclusions
13Appendix

For more information or any query mail at sales@wiseguyreports.com

About Us
Wise Guy Reports is part of the Wise Guy Consultants Pvt. Ltd. and offers premium progressive statistical surveying, market research reports, analysis & forecast data for industries and governments around the globe. Wise Guy Reports understand how essential statistical surveying information is for your organization or association. Therefore, we have associated with the top publishers and research firms all specialized in specific domains, ensuring you will receive the most reliable and up to date research data available.

Norah Trent
WISEGUY RESEARCH CONSULTANTS PVT LTD
08411985042
email us here


Source: EIN Presswire

The Global Cancer Clinical Decision Tools Market Share Will Grow At 10.23% CAGR To 2023

Cancer Clinical Decision Tools Market Report 2020-30: COVID-19 Growth And Change

Cancer Clinical Decision Tools Global Market Report 2020-30: COVID-19 Growth And Change

The Business Research Company’s Global Cancer Clinical Decision Tools Market Report 2020-30: COVID-19 Growth And Change

LONDON, GREATER LONDON, UK, October 27, 2020 /EINPresswire.com/ — The global cancer clinical decision support market size is expected to decline from $0.38 billion in 2019 to $0.35 billion in 2020 at a compound annual growth rate (CAGR) of -7.41%. The decline is mainly due to the COVID-19 outbreak that has deferred treatment for cancer unless the conditions are serious. The global cancer clinical decision tools market share is then expected to recover and reach $0.47 billion in 2023 at a CAGR of 10.23%.

The rise in the number of cancer cases across the globe is likely to contribute to the growth of the cancer clinical decision tools market. According to the National Cancer Institute, the rate of incidence based on cases between 2013–2017 cases is 442.4 per 100,000 men and women per year. According to the American Cancer Society, there were 1.7 million new cases and 0.6 cancer deaths in 2019 in the USA. The four most common types of cancers worldwide are lung, prostate, bowel, and female breast cancer, accounting for 43% of all new cancer cases. Therefore, the rise in cancer incidence rates across the globe will increase the demand for cancer clinical decision tools to make treatment decisions faster, thereby contributing to the market growth.

The cancer clinical decision tools market consists of sales of cancer decision support tools and related services. Cancer decision tools are designed to support the general practitioner’s assessment of patients with potential cancer symptoms. The tools do not change the clinical judgment but give more information that is used to inform patient management decisions. The risk is measured based on reading coded information from the patient record including demographic data, medical history, and symptoms.

The global cancer clinical decision tools market is segmented by type into Risk Assessment Tool (RAT) and Qcancer. By End-User, the market is segmented into hospital and clinics.

The breach of data and privacy of patients is a major challenge in the cancer clinical decision tools market. Hackers can get access to data centers through healthcare employee’s emails leading to a breach of patients’ information privacy. For instance, in 2019, the Regional Cancer Care Association (RCCA) reported a data breach through phishing email attempts. Email phishing is a primary attack because it is not detectable by email security tools. Similarly, in 2018, out of 15 million patient records breached, 11.4 million records were caused by phishing attacks. The risk of the loss of data and privacy of patients harms the growth of the cancer clinical decision tools market.

The major players covered in the global cancer clinical decision tools market are McKesson Corporation, Medical Information Technology Inc., Philips Healthcare, Siemens Healthineers, Elsevier B.V., Macmillan, and National Decision Support Company.

Here Is A List Of Similar Reports By The Business Research Company:

Cancer Diagnostics Global Market Report 2020-30: Covid 19 Growth And Change
(https://www.thebusinessresearchcompany.com/report/cancer-diagnostics-global-market-report)

Cancer Biologics Global Market Report 2020-30: Covid 19 Growth And Change
(https://www.thebusinessresearchcompany.com/report/cancer-biologics-global-market-report)

Interested to know more about The Business Research Company?
The Business Research Company is a market intelligence firm that excels in company, market, and consumer research. Located globally it has specialist consultants in a wide range of industries including manufacturing, healthcare, financial services, chemicals, and technology.

Oliver Guirdham
The Business Research Company
+44 20 7193 0708
email us here
Visit us on social media:
Facebook
Twitter
LinkedIn


Source: EIN Presswire

Delaware US Navy Veterans Lung Cancer Advocate Appeals to the Family of a Navy Veteran in Delaware with Lung Cancer Who Also Had Asbestos Exposure to Asbestos to Call the Lawyers at Karst von Oiste About Compensation

"Most Navy Veterans who had heavy exposure to asbestos decades ago and develop lung cancer never get compensated-even though most should-as the lawyers at Karst von Oiste at 800-714-0303 will explain.”

— Delaware US Navy Veterans Lung Cancer Advocate

WILMINGTON , DELAWARE , USA, October 27, 2020 /EINPresswire.com/ — The Delaware US Navy Veterans Lung Cancer Advocate says, "We are appealing to the member of the American Legion or VFW who has a Navy Veteran friend with lung cancer in Delaware to ask him if he had heavy exposure to asbestos in the navy in the 1960s, or 1970s? If the answer is yes-he did–please ask his wife or family to call the lawyers at the law firm of Karst von Oiste anytime at 800-714-0303. Financial compensation for a person like this might exceed $100,000 and it does not involve suing the navy. The average Navy Veteran we are trying to identify is well over 60 years old and it does not matter if he smoked cigarettes. Most people like this do not realize that the $30 billion dollar-asbestos trust funds were set up for them too." www.karstvonoiste.com/

The lawyers at the law firm of Karst von Oiste have been assisting Navy Veterans and people with asbestos exposure lung cancer and mesothelioma for decades and they are responsible for over a billion dollars for people like this. "Most Navy Veterans who had heavy exposure to asbestos decades ago and develop lung cancer never get compensated-even if they should. For direct access to the lawyers at Karst von Oiste please call 800-714-0303 anytime." www.karstvonoiste.com/

The Delaware US Navy Veterans Lung Cancer Advocate’s free services are available to people with asbestos exposure lung cancer or mesothelioma in Wilmington, Dover, Newark, Middletown, Smyrna, Milford, Seaford or anywhere in Connecticut. https://Delaware.USNavyLungCancer.Com

High risk occupations for asbestos exposure in Delaware include the US Navy, chemical plant workers, Dover Air Force Base, power plant workers, public utility workers, plumbers, electricians, construction workers, welders, machinists, power plant workers, public utility workers, and auto mechanics. https://USNavyLungCancer.Com

According to the American Cancer Society for nonsmokers who have been exposed to asbestos in their workplace the risk of lung cancer is five times that of unexposed workers. https://www.cdc.gov/cancer/lung/statistics/index.htm.

The US Navy Veterans Lung Cancer Advocate says, “If your husband, dad, coworker or neighbor has just been diagnosed with lung cancer and you know they had significant exposure to asbestos in the navy, at a shipyard or while working at a factory, at power plant, public utility, or as a plumber, electrician welder, mechanic or any kind of skilled trades group in any state please have them call us anytime at 800-714-0303. Most people like this never get compensated-even though the asbestos trust funds were set up for them too. We are trying to change this sad fact.” https://USNavyLungCancer.Com

States with the highest incidence of lung cancer include Kentucky, West Virginia, Maine, Tennessee, Mississippi, Ohio, Indiana, Louisiana, Arkansas, Missouri, North Carolina, Rhode Island, Alabama, and Delaware. www.karstvonoiste.com/

For more information about asbestos exposure please visit the NIH’s website on this topic: https://www.cancer.gov/about-cancer/causes-prevention/risk/substances/asbestos/asbestos-fact-sheet.

Michael Thomas
Delaware US Navy Veterans Lung Cancer Advocate
+1 800-714-0303
email us here


Source: EIN Presswire

BetterPT and PromptEMR Announce Enhanced Telehealth Services and Scheduling Integration for Outpatient Physical Therapy

BetterPT

BetterPT – We are building the epicenter for healthcare

PromptEMR

Seamlessly integrated and easy to use. Prompt is built to transform your practice.

Bidirectional integration provides greater efficiency for the clinic staff and better customer experience for patients when scheduling appointments.

NEW YORK, NEW YORK, UNITED STATES, October 27, 2020 /EINPresswire.com/ — BetterPT™, a technology company committed to facilitating and improving patient access and experience with healthcare services, has enhanced its telehealth platform capabilities with PromptEMR, a fully integrated enterprise solution to manage outpatient PT clinics, by including a bidirectional integration that allows clinics to manage inbound and outbound patient requests with fewer steps and greater ease.

BetterPT and PromptEMR are uniquely positioned to deliver the technology and services that enable therapy providers to maintain continuity of care for patients from the safety and comfort of their homes or offices. The comprehensive single solution allows PT clinics to improve their efficiency and grow profitability by optimizing operational workflows. In addition, it enables clinics to secure qualified patient appointments and provide a seamless and enhanced patient experience.

BetterPT’s integrated, easy-to-use, HIPAA compliant virtual care platform, BetterTelehealth, is now fully embedded within PromptEMR’s software solution. Patients have the option to schedule telehealth appointments directly from their desktop or mobile device using a mobile app, QR code, or website widget. The inbound patient information flows directly into PromptEMR’s system allowing clinic staff to manage those appointments from within PromptEMR’s dashboard. This embedded integration also allows clinic staff to create an outbound Telehealth appointment for a patient directly from PromptEMR’s scheduling platform without the need to log into BetterPT. This bidirectional integration offers operational efficiencies, helping to cut down administrative burden and paperwork, and a better patient experience with telehealth.

“For patients, establishing a routine with their treatments is necessary. This enhanced integration with PromptEMR will help ensure that therapists are able to provide that continuity of care, while providing greater efficiency and flexibility to clinics,” said Greg Peters, CEO of BetterPT. “Through our integrated healthcare platforms, physical therapy clinics are able to easily incorporate virtual services into their patient’s course of care ensuring the delivery of physical therapy and other types of services does not decrease, especially during these unprecedented times.”  

“Physical therapy clinics are facing a number of increased challenges today, including a patient population that desires an alternative to in-person visits. We believe that telehealth is here to stay and we want to equip practices with the best possible solution to facilitate it,” said Ray Baliatico, CEO of Prompt EMR. “We are delighted to expand our partnership with BetterPT to provide a unique, integrated solution for today’s modern physical therapy practice, which allows clinics to grow their businesses by helping qualified patients find their practices, easily convert them to in-person or virtual visits, efficiently on-board and process them, and ultimately focus greater time and energy on providing quality care to patients.”

About BetterPT 
BetterPT™ is a technology company, committed to facilitating access to global healthcare services and improving the patient experience by connecting the three stakeholders in the healthcare ecosystem: patients, providers, and payers. With an interoperable, HIPAA compliant application and EMR compatibility, BetterPT enables patients to access preventive care through in-office, virtual, and on-demand appointments. Its unique marketplace model provides an entry-point for patients seeking physical therapy care. For more information, please visit please visit BetterPT.com or follow us on Facebook, Instagram, LinkedIn, and Twitter.  

About PromptEMR
PromptEMR is a fully-integrated enterprise platform that provides end-to-end business management software for the physical therapy industry. PromptEMR is an easy-to-use, mobile-friendly, click-based system that streamlines workflows for every user within a clinic, driving improved efficiency, profitability, and patient care. PromptEMR addresses online patient scheduling, electronic onboarding, in-clinic scheduling, patient management, documentation, billing, reporting, and analytics, allowing a clinic to utilize one piece of software to manage their entire business. Our mission is to allow therapists to focus on patient care rather than managing multiple legacy software systems. Prompt provides a HIPAA-compliant, web-based solution that works on any device, reducing the friction of managing a clinic. PromptEMR’s streamlined workflows enable every user within a clinic to optimize for patient experience by eliminating cumbersome data-entry, which drives higher clinic profitability. For more information, please visit www.promptemr.com

Marla Ranieri
BetterPT
+1 917-768-2525
marla@betterpt.com
Visit us on social media:
Facebook
Twitter
LinkedIn


Source: EIN Presswire

Tennessee US Navy Veterans Mesothelioma Advocate Has Endorsed Attorney Erik Karst of Karst von Oiste to Make Certain a Navy Veteran in Tennessee Gets the Best Possible Compensation Results-Demand the Best

"If you call attorney Erik Karst of the law firm of Karst von Oiste at 800-714-0303-he will answer your questions about mesothelioma-and if you like him-hire him. Erik Karst has our 100% endorsement.”

— Tennessee US Navy Veterans Mesothelioma Advocate

MEMPHIS, TENNESSEE , USA, October 27, 2020 /EINPresswire.com/ — According to the Tennessee US Navy Veteran Mesothelioma Advocate, "We have endorsed and we highly recommend attorney Erik Karst of the law firm of Karst von Oiste to make certain a Navy Veteran with mesothelioma in Tennessee receives the very best possible financial compensation results. If you are a Navy Veteran with mesothelioma in Tennessee or their family-please call Erik Karst anytime at 800-714-0303 for specific answers to your questions about mesothelioma compensation-and or how the process works.

"Financial compensation for a Navy Veteran with mesothelioma might exceed a million dollars-if the lawyers you hire know what they are doing. Erik Karst and his team at Karst von Oiste have been assisting Navy Veterans with mesothelioma for decades and they are responsible for over a billion dollars in compensation results for their clients. We know the lure of 'free' booklets, guides, calculators and all of this nonsense might sound interesting–please do not do this–unless you want to get hounded night and day by lawyers you have never heard of. If you call attorney Erik Karst of the law firm of Karst von Oiste at 800-714-0303-he will answer your questions-and if you like him-hire him." www.karstvonoiste.com/

The US Navy Veterans Mesothelioma Advocate offers their free services to a US Navy Veterans with mesothelioma in Memphis, Nashville, Knoxville, Chattanooga, Clarksville or anywhere in Tennessee. https://Tennessee.USNavyMesothelioma.Com

For the best possible mesothelioma treatment options in Tennessee the Tennessee US Navy Veterans Mesothelioma Advocate strongly recommends the following two heath care facilities with the offer to help a diagnosed victim, or their family get to the right physicians at each hospital.

* The Vanderbilt-Ingram Cancer Center, Nashville: https://www.vanderbilthealth.com/cancer/.

* Baptist Memorial Hospital in Memphis: http://www.baptistonline.org/memphis

About one third of all US citizens diagnosed with mesothelioma each year are Veterans of the US Navy. Before a Navy Veteran with mesothelioma or their family retain the services of a lawyer or law firm, they are urged to call the US Navy Veterans Mesothelioma Advocate at 800-714-0303.
https://USNavyMesothelioma.Com

The states with the highest incidence of mesothelioma include Maine, Massachusetts, Connecticut, Maryland, New Jersey, Pennsylvania, Ohio, West Virginia, Virginia, Michigan, Illinois, Minnesota, Louisiana, Washington, and Oregon. www.karstvonoiste.com/

For more information about mesothelioma please refer to the National Institutes of Health’s web site related to this rare form of cancer: https://www.cancer.gov/types/mesothelioma

Michael Thomas
Tennessee US Navy Veterans Mesothelioma Advocate
+1 800-714-0303
email us here


Source: EIN Presswire

Fabry Disease Market 2020 Pipeline Analysis, Opportunities And Forecast to 2025

Wiseguyreports.Com Adds “Fabry Disease -Market Demand, Growth, Opportunities and Analysis Of Top Key Player Forecast To 2025” To Its Research Database

PUNE, MAHARASHTRA, INDIA, October 27, 2020 /EINPresswire.com/ — Fabry Disease Industry

Description

Wiseguyreports.Com Adds “Fabry Disease -Market Demand, Growth, Opportunities and Analysis Of Top Key Player Forecast To 2025” To Its Research Database

Fabry Disease (also known as Anderson Fabry Disease) is a progressive X linked inherited genetic disorder of glycosphingolipid metabolism due to deficient or absent lysosomal α-galactosidase A activity. It is a devastating inborn error of metabolism with, particularly in the early stages, being played by cellular dysfunction and microvascular pathology being induced by lysosomal glycosphingolipid deposition. The absence or deficient activity of lysosomal exoglycohydrolase α-galactosidase A results in the progressive accumulation of globotriaosylceramide and related glycosphingolipids within lysosomes which are ubiquitous subcellular organelles.

The first clinical symptoms interfering with the child's well-being and performance arise in childhood, typically between the ages of 3 and 10 years, and generally a few years later in girls than in boys. With age, progressive damage to vital organ systems develops in both genders leading to organ failure. End-stage renal disease and life-threatening cardiovascular or cerebrovascular complications limit life-expectancy. The clinical signs are multisystemic, heterogeneous, and progressive.

Request For Sample Report @ https://www.wiseguyreports.com/sample-request/5762578-fabry-disease-pipeline-analysis-2019

The biochemical diagnosis of Fabry Disease is established by measuring α-gal A activity in plasma or leukocytes taken from peripheral blood, cultured fibroblasts or using the samples extracted from the filter paper blood spots. The diagnosis of FD can arise from careful clinical and instrumental investigations, together with family history data and accurate interpretation of genetic and enzymatic analyses. Identification of a hemizygous GLA pathogenic variant by molecular genetic testing confirms the diagnosis in a male proband.

The therapeutic pipeline of Fabry Disease consists of approximately 9+ products in different stages of development. Currently, 2+ drugs are in Phase III development and major drugs are in pre-clinical stage.

Top Company Analysed

Some of the key players include Amicus Therapeutics; Evotec; Freeline; Greenovation Biotech; Idorsia Pharmaceuticals; Moderna; Pharming; Protalix Biotherapeutics; Resverlogix Corp; Sangamo Therapeutics and Sanofi Genzyme.

Scope of the report:

• Provides an overview of therapeutic pipeline activity for Fabry Disease across the complete product development cycle including all clinical and non-clinical stages
• The report comprises of detailed profiles of Fabry Disease therapeutic products with key coverage of developmental activities including licensing & collaboration deals, patents issued, designations, technologies and chemical information
• Therapeutic assessment of the active pipeline products by stage, product type, molecule type, and route of administration
• Detailed profiles of the dormant products have been included in the report

Leave a Query @ https://www.wiseguyreports.com/enquiry/5762578-fabry-disease-pipeline-analysis-2019

Reasons to buy:

• The Fabry Disease pipeline presents the detailed profile of drugs. The analysis offered in the report is a combination of deep dive secondary research and input from Key Opinion Leader of the industry
• The report presents a quick review of the current scenario regarding the drug development of the indication at one glance
• The report covers in-depth analysis of prominent industry peers with a primary focus on company consolidation, designation, technology, agreements and patents regarding the therapy
• Detailed examination on diagnosis, treatment and guidelines prevailing in the industry
• Examination of industry attractiveness with the help of launch timelines
• The study comprehensively covers the market across drugs in different phases of development
• Extensive domain knowledge on therapy areas support the client in decision-making process regarding their therapeutic portfolio by identifying the reason behind the inactive or discontinued products

Customization Options:

The Fabry Disease pipeline analysis report can be customized to the country level or any other competitive segment. Besides this, UMI understands that you may have your own business need, hence we also provide fully customized solutions to clients.

Table of Content

1. REPORT INTRODUCTION

2. DISEASE OVERVIEW 9

3. PIPELINE THERAPEUTICS AT A GLANCE 38

4. COMPARATIVE ANALYSIS 39

5. LATE PHASE PRODUCTS (PHASE III) 40

6. MID PHASE PRODUCTS (PHASE II) 50

7. EARLY STAGE PRODUCTS (PHASE I) 53

8. PRE-CLINICAL STAGE PRODUCTS 58

9. THERAPEUTIC ASSESSMENT 65

10. APPROVAL TIMELINES 70

11. ANALYST INSIGHTS 71

12. INACTIVE PRODUCTS 72

Buy Now @ https://www.wiseguyreports.com/checkout?currency=one_user-USD&report_id=5762578

Continued…           

Contact Us: Sales@Wiseguyreports.com Ph: +1-646-845-9349 (Us)  Ph: +44 208 133 9349 (Uk)

NORAH TRENT
WISE GUY RESEARCH CONSULTANTS PVT LTD
646-845-9349
email us here


Source: EIN Presswire

Infant Nutrition Market Expected to Reach $61.6 Billion by 2026 | CAGR 7.7%

Infant Nutrition Market

Infant Nutrition Market

Demand for infant nutrient is higher in the emerging countries, as they are equally growing in terms of money and population.

Companies need to address rapidly changing consumer needs to cater to their emerging demand. Moreover, evolution of online sale of infant nutrition products would further increase the overall revenue.”

— Nisha Dodeja

PORTLAND, OR, UNITED STATES, October 27, 2020 /EINPresswire.com/ — According to a new report published by Allied Market Research, titled, " Infant Nutrition Market by Product Type, Form, and Distribution Channel: Global Opportunity Analysis and Industry Forecast, 2019-2026,” the global infant nutrition market size was valued at $34.2 billion in 2018, and is projected to reach $61.6 billion by 2026, registering a CAGR of 7.7% from 2019 to 2026. The most significant factor that influences a child growth and development is nutrition. Infant nutrition are produced for feeding babies and infants, which are usually under 12 month of age and also it is prepared from liquid or powder. Infant nutrition facilitates healthy growth and development of babies, improves cognitive performance and development, prevents them from allergies, and increases gastrointestinal health & immunity. The global infant nutrition market analysis is segmented on the basis of product type, form, distribution channel and region.

According to Federal Food, Drug, and Cosmetic Act, infant nutrition means a food that purports to be or is represented for special dietary use solely as a food for infants by reason of its simulation of human milk or its suitability as a complete or partial substitute for human milk.

Get the Complete Report & TOC: https://www.alliedmarketresearch.com/request-sample/6165

The number of women as a part of the labor workforce has increased over the past few years due to rise in literacy rate. The ratio is estimated to increase in the near future, owing to the supportive government policies. The ease and convenience provided by these baby products offer parents lesser time in manual preparation of baby foods and simultaneously take care of the babies, which is expected to boost the infant nutrition market demand during the forecast period.

Moreover, consumer prefer to purchase infant nutrition from stores such as supermarkets and retail stores; however, this scenario is changing and customers are moving toward online channels. Online sales have evolved as a key source of revenue for many companies. The online sales market is expected to expand at a higher rate in the near future owing to the rapid penetration of smartphones, increase in m-commerce sales, and ease in payment options. However, the collaborative initiatives of various organizations, such as World Health Organization (WHO) and United Nations International Children’s Emergency Fund (UNICEF), have increased the overall awareness about breastfeeding among women. This in turn limits the overall revenue generation for the global infant nutrition market.

Get detailed COVID-19 impact analysis on the Infant Nutrition Market: https://www.alliedmarketresearch.com/request-for-customization/6165?reqfor=covid

Continuous innovation in product functionality and performance along with coherent strategies such as tailored packaging, which reflect the healthy ingredients in the sustaining infant nutrition market trends, allow major players in the market to sustain in the consumer-centric market. Moreover, attractive and convenient packaging acts as a key selling point for leading manufacturers. As a result, prominent players in the market have introduced baby food in a variety of packaging formats, including, but not limited to stand up pouches, glass & plastic containers, cans, and others.

Key Findings of the Infant Nutrition Market :

Based on product type, the infant milk segment dominates the global infant nutrition market in 2018, and is expected to retain its dominance throughout the forecast period.
Depending on form, the solid segment accounted for highest share in the infant nutrition market growth in 2018, and is projected to grow at a CAGR of 7.5% from 2019 to 2026.
By distribution channel, the pharmacy segment was the major shareholder in 2018, and is projected to register a CAGR of 8.1% from 2019 to 2026.
Region wise, Asia-Pacific accounted for about 44.2% infant nutrition market share in 2018, and is expected to grow at a CAGR of 8.2%.

Buy this report now: https://www.alliedmarketresearch.com/purchase-enquiry/6165

The key players operating in the infant nutrition industry include Abbott, Arla Foods Amba, Campbell Soups, Dana Dairy Group Ltd., Danone, Nestle S.A., Reckitt Benckise (Mead Johnson & Company LLC), Perrigo Company Plc, Heinz Baby, and Gujarat Co-operative Milk Marketing Federation Ltd. (GCMMF).

Similar Reports:
Greek Yogurt Market Expected to Reach $11.2 Billion by 2027
Global Lactose Free Butter Market Expected to Reach $388.4 Million by 2026

Upcoming Reports:
Fermented Non-Dairy Beverages Market: https://www.alliedmarketresearch.com/fermented-non-dairy-beverages-market
Extruded Snack Food Market: https://www.alliedmarketresearch.com/extruded-snack-food-market

About Allied Market Research:

Allied Market Research (AMR) is a full-service market research and business-consulting wing of Allied Analytics LLP based in Portland, Oregon. Allied Market Research provides global enterprises as well as medium and small businesses with unmatched quality of “Market Research Reports” and “Business Intelligence Solutions.” AMR has a targeted view to provide business insights and consulting to assist its clients to make strategic business decisions and achieve sustainable growth in their respective market domains. AMR offers its services across 11 industry verticals including Life Sciences, Consumer Goods, Materials & Chemicals, Construction & Manufacturing, Food & Beverages, Energy & Power, Semiconductor & Electronics, Automotive & Transportation, ICT & Media, Aerospace & Defense, and BFSI.

We are in professional corporate relations with various companies and this helps us in digging out market data that helps us generate accurate research data tables and confirms utmost accuracy in our market forecasting. Each and every data presented in the reports published by us is extracted through primary interviews with top officials from leading companies of domain concerned. Our secondary data procurement methodology includes deep online and offline research and discussion with knowledgeable professionals and analysts in the industry.

David Correa
Allied Analytics LLP
+1 800-792-5285
email us here
Visit us on social media:
Facebook
Twitter
LinkedIn

Avenue.! An Online Subscription Based Library of Reports – Allied Market Research


Source: EIN Presswire